Enibarcimab
Enibarcimab is a humanised murine monoclonal immunoglobulin G1 (IgG1) antibody, could be used for acute heart failure, COVID-19 infections and septic shock research[1].
Product Specifications
CAS Number
[2305638-98-4]
UNSPSC
12352203
Target
SARS-CoV
Type
Inhibitory Antibodies
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection; Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/enibarcimab.html
Purity
99.68
Solubility
10 mM in DMSO
Smiles
[Enibarcimab]
Molecular Weight
(145.82 kDa)
References & Citations
[1]James E, et al. The Immune System and Chronic Heart Failure: Is the Heart in Control? Journal of the American College of Cardiology. 2019. 53 (12) :1013-1020.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
127628-AP 100 µL
GTF2A2 (Transcription Initiation Factor IIA Subunit 2, General Transcription Factor IIA Subunit 2, TFIIA p12 Subunit, TFIIA-12, TFIIAS, Transcription Initiation Factor IIA gamma Chain, TFIIA-gamma, TF2A2) (AP) discontinued
Ask
View Details 
